Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
about
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDouble or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelEmerging Tools for Stroke Prevention in Atrial FibrillationThe case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratioTreatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.The critical care management of spontaneous intracranial hemorrhage: a contemporary reviewGuidelines on oral anticoagulation with warfarin - fourth editionAntidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control studyThe risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.The golden age of minimally invasive cardiothoracic surgery: current and future perspectives.Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit.Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center RegistryThe challenge of bleeding in antiphospholipid antibody-positive patients.Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationManagement of anticoagulant-related intracranial hemorrhage: an evidence-based review.A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risksAcetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyAspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.Warfarin therapy in a dog with acute arterial thrombosis and pyometra.Shared decision making in patients with stable coronary artery disease: PCI choice.Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesStudy protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcareSystematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective.Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.Antidepressants, antiplatelets and bleeding: one more thing to worry about?Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay.Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSubtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED scoreDual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
P2860
Q24632951-DB6BE1FC-64A7-4BC4-975F-18F7B406D475Q26741058-C231C6A5-CDA1-4731-B0F2-DF265C913EDBQ26765023-FE2498C9-8C1E-4492-8389-8323E0A27694Q26776239-0A15C157-5BFD-47E0-9873-94321F3DC52FQ26866350-06D1285B-D112-48A2-B2BD-64C87F91069BQ27341873-2E857069-2A7D-4EB3-9F3A-744476F5017DQ28067962-3AD5127B-BD85-48FD-B118-67BDEFEFBD9DQ28240666-571B3B86-A4D3-4518-AF47-8C84D15BEA2FQ28478738-2536A909-D6E6-49A1-AE8F-BD908BA192E6Q30234909-A5AB70DF-1CD0-4757-8F7A-8853786300E8Q30469960-2A2680FA-2F07-4074-B375-7DBB83E00D1DQ30713413-B8057B16-B4BB-496C-AF3D-962DA15FB84CQ30853679-8F6A927D-85DA-45AC-BE77-6DAB2FC630C2Q31001917-DC1A016A-1028-4074-8CF7-341346FB5D7EQ33419972-FB78E2ED-6B5A-40E8-837B-505B1DBD76A8Q33651588-058C5DBB-E5B6-4A03-89FD-099432FE8534Q33750215-C1DAA90E-6486-488B-A53C-C347C015AD54Q33949244-D70D14AA-106F-42E9-AF1D-571454DE16B8Q33949522-86C938BE-88FF-4D24-A147-BCD50DE73665Q34252907-21ACFD9C-FCF1-4FDA-B4C0-079833384F7BQ34343069-571E25FE-74FD-42F9-AD1C-6BC4AF28F1F4Q34364050-645E6C0C-BEB5-462F-A8EA-207AF00DF235Q34379426-E6907299-3E21-4374-907A-FA9AA4E010E0Q34505058-9E1ABA21-F61B-42B2-9A65-5395995FB053Q34585334-46B4551A-BFC2-4C25-A381-441DCC3ACAD0Q35063716-92949DA1-F99A-4278-9150-16576A6617EAQ35093560-0FA62820-E4EF-412F-AA24-CC7E450A7073Q35161633-8EF7C5D4-0685-4B2D-9053-1DC486192E13Q35181596-6EC5D21D-5FC5-4229-ABFA-56C07CD576C7Q35335927-D49E8016-3F6B-4636-994D-FE9EC3D5DFD2Q35551111-8967FD7D-C90E-404D-B5A1-11643E6142CBQ35553343-D2266EDC-B09A-4CDB-88B3-8DE65E030468Q35609742-336CC6C3-7426-4829-8BF1-905708EFB37EQ35714803-79E68ACD-108D-4145-9663-3C902C85764FQ35746798-7EBAC064-B971-4CFE-A9DB-ADC09B904F87Q35752573-1785D5FE-CBBD-4FD8-BB78-AED09C11921BQ35903857-CAF0CC33-520C-475F-A88A-4EC5F9705385Q35962795-11B89412-81CD-47F2-A72A-EA1863C8CE44Q36088769-0D70EC5C-260A-4195-B7C9-B04DDDE3A5BEQ36113146-AC3FC8F5-C730-453D-91BB-343CBD0750B2
P2860
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Risk of bleeding with single, ...... ents with atrial fibrillation.
@en
Risk of bleeding with single, ...... ents with atrial fibrillation.
@nl
type
label
Risk of bleeding with single, ...... ents with atrial fibrillation.
@en
Risk of bleeding with single, ...... ents with atrial fibrillation.
@nl
prefLabel
Risk of bleeding with single, ...... ents with atrial fibrillation.
@en
Risk of bleeding with single, ...... ents with atrial fibrillation.
@nl
P2093
P50
P921
P1476
Risk of bleeding with single, ...... ents with atrial fibrillation.
@en
P2093
Jakob Raunsø
Marie Louise Fog-Petersen
Mette T Clausen
Morten L Hansen
Niels Gadsbøll
Rikke Sørensen
Steen Z Abildstrøm
Søren S Andersen
Tina K Schramm
P304
P356
10.1001/ARCHINTERNMED.2010.271
P407
P577
2010-09-01T00:00:00Z